When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 vistas
• 07/10/23
0
0
Empotrar
administrator
Suscriptores
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios